ID   p34
AC   CVCL_UW54
SY   p 34
DR   Wikidata; Q98128421
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=16141719;
CC   Doubling time: 16 hours (PubMed=16141719).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 4
//
RX   DOI=10.4172/2324-9293.1000104;
RA   Wagenhauser, Markus Udo
RA   Ruckert, Felix
RA   Niedergethmann, Marco
RA   Grutzmann, Robert
RA   Saeger, Hans-Detlev
RT   "Distribution of characteristic mutations in native ductal
RT   adenocarcinoma of the pancreas and pancreatic cancer cell lines.";
RL   Cell Biol. Res. Ther. 2:1000104.1-1000104.5(2013).
//
RX   PubMed=16141719; DOI=10.1159/000088071;
RA   Starr, Alexander N.
RA   Vexler, Akiva
RA   Marmor, Silvia
RA   Konik, D.
RA   Ashkenasi-Voghera, Maia
RA   Lev-Ari, Shahar
RA   Greif, Yoel
RA   Ben-Yosef, Rahamim
RT   "Establishment and characterization of a pancreatic carcinoma cell
RT   line derived from malignant pleural effusion.";
RL   Oncology 69:239-245(2005).
//